Oral contraceptive and progestin-only use correlates to tissue tumor marker expression in women with cervical intraepithelial neoplasia

Contraception

Volumn 85, Issue 3, 2012, Pages 288-293

  Samir, Raghad ^a,b   Asplund, Anna ^c   Tot, Tibor ^a   Pekar, Gyula ^a   Hellberg, Dan ^b,c  

^a FALUN HOSPITAL   (Sweden)

^b Center for Clinical Research   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Biological markers; Cervical intraepithelial neoplasia; Gestagen; Medicated intrauterine device; Oral contraceptives

Indexed keywords

CD4 ANTIGEN; CYCLOOXYGENASE 2; CYTOKERATIN 10; EPIDERMAL GROWTH FACTOR RECEPTOR; FRAGILE HISTIDINE TRIAD PROTEIN; GESTAGEN; INTERLEUKIN 10; KI 67 ANTIGEN; ORAL CONTRACEPTIVE AGENT; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR MARKER; UVOMORULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAUTERINE CONTRACEPTIVE DEVICE; PROTEIN EXPRESSION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; PROGESTINS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84856707962     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.09.001     Document Type: Article

References (33)

1. International Collaboration of Epidemiological Studies of Cervical Cancer Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16573 women with cervical cancer and 35509 women without cervical cancer from 24 epidemiological studies Lancet 1609 2007 1609 1621
2. J. Green, A. Berrington de Gonzales, and J.S. Smith Human papillomavirus infection and use of oral contraceptives Br J Cancer 88 2003 1713 1720 (Pubitemid 36760415)
3. X. Castellsague, and N. Munoz Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking J Natl Cancer Inst Monogr 31 2003 20 28
4. M. Moodley, J. Moodley, R. Chetty, and C.S. Herrington The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review Int J Gynecol Cancer 13 2003 103 110 (Pubitemid 37055462)
5. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous-cell cervical cancer Contraception 45 1992 299 312
6. C.J. Prasad, E. Sheets, A.M. Selig, M.C. McArthur, and C.P. Crum The binucleate squamous cell: histologic spectrum and relationship to low-grade squamous intraepithelial lesions Mod Pathol 6 1993 313 317
7. D. Carter, J.K. Greenson, V.E. Reuter, and M.H. Stoler 4th ed. Sternberg's diagnostic surgical pathology vol. 2 2004 Wolter Kluwer, Lippincott Williams & Wilkins Philadelphia 2377 2392
8. M. Uhlen, and F. Ponten Antibody-based proteomics for human tissue profiling Mol Cell Proteomics 4 2005 384 393 (Pubitemid 40590558)
9. J.L. Young, A.A. Jazaeri, C.J. Darus, and S.C. Modesitt Cyclooxygenase-2 in cervical neoplasia: a review Gynecol Oncol 109 2008 140 145
10. A.K. Lindström, U. Stendahl, T. Tot, B.M. Lidström, and D. Hellberg Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expression Anticancer Res 27 2007 1609 1616
11. C.W. Critchlow, P. Wolner-Hanssen, and D.A. Eschenbach Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking and douching Am J Obstet Gynecol 173 1995 534 543
12. H. Maia, and J. Casoy Non-contraceptive health benefits of oral contraceptives Eur J Contracept Reprod Health Care 13 2008 17 24 (Pubitemid 351271845)
13. M. Taniguchi, T. Tashiro, N. Dashtsoodol, N. Hongo, and H. Watarai The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy Jpn Soc Immunol 22 2009 1 6
14. J.M. Alcocer-Gonzales, J. Berumen, and R. Tamez-Guerra In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells Viral Immunol 19 2006 481 491 (Pubitemid 44735060)
15. P.E. Gravitt, A. Hildesheim, and R. Herrero Correlates of IL-10 and IL-2 concentrations in cervical secretions J Clin Immunol 23 2003 175 183 (Pubitemid 36521211)
16. M.E. Scott, Y. Ma, and S. Farhat Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking J Clin Immunol 26 2006 222 232 (Pubitemid 43901651)
17. K.K. Azar, M. Tani, H. Yasuda, A. Sakai, M. Inoue, and T. Sasagawa Increased secretion pattern of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions Hum Pathol 35 2004 1376 1384 (Pubitemid 39601578)
18. R.K. Bhairavabhotla, V. Verma, H. Tongaonkar, S. Shastri, K. Dinshaw, and S. Chiplunkar Role of IL-10 in immune suppression in cervical cancer Indian J Biochem Biophys 44 2007 350 356 (Pubitemid 351481352)
19. Y. Enomoto, K. Enomoto, T. Kitamura, and T. Kanda Keratinocyte-specific POU transcription factor hSkn-1a represses the growth of cervical cancer cell lines Oncogene 23 2004 5014 5022 (Pubitemid 38938734)
20. P. Maddox, A. Szarewski, J. Dyson, and J. Cuzick Cytokeratin expression and acetowhite change in cervical epithelium J Clin Pathol 47 1994 15 17 (Pubitemid 24057741)
21. B. Daniel, A. Rangarajan, G. Mukherjee, and E. Vallikad The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions J Gen Virol 78 1997 1095 1101 (Pubitemid 27207596)
22. P.F. van Bommel, P. Kenemans, T.J. Helmerhorst, M.P. Gallee, and D. Ivanyi Expression of cytokeratin 10, 13 and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix Cancer 74 1994 2314 2320 (Pubitemid 24322287)
23. A.S. Coutts, and N.B. La Thangue The p53 response: emerging levels of co-factor complexity Biochem Biophys Res Comm 331 2005 778 785 (Pubitemid 40615508)
24. A.K. Lindström, U. Ulf Stendahl, T. Tot, and D. Hellberg Associations between ten biological tumor markers in squamous cell cervical cancer and serum estradiol, serum progesterone and smoking Anticancer Res 27 2007 1401 1406 (Pubitemid 46807215)
25. Y. Zalel, R. Gamzu, A. Shulman, R. Achiron, G. Schiff, and A. Lidor The progestative effect of levonorgestrel-releasing intrauterine system - when does it manifest? Contraception 67 2003 473 476 (Pubitemid 36695113)
26. T. Luukkainen, and J. Toivonen Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties Contraception 52 1995 269 276
27. P. Lähteenmäki, I. Rauramo, and T. Backman The levonorgestrel intrauterine system in contraception Steroids 65 2000 693 697
28. T. Luukainen, P. Lähteenmäki, and J. Toivonen Levonorgestrel-releasing intrauterine device Ann Med 22 1990 85 90 (Pubitemid 20193529)
29. J.S. Misra, A.D. Engineer, and P. Tandon Cervical cytology associated with levonorgestrel contraception Acta Cytol 39 1995 45 49
30. T. Lessard, J.A. Simoes, M.G. Discacciati, M. Hidalgo, and L. Bahamondes Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system Contraception 77 2008 30 33
31. T. Crook, A. Storey, N. Almond, K. Osborn, and L. Crawford Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells Proc Natl Acad Sci U S A 85 1988 8820 8824 (Pubitemid 19001797)
32. K.J. Auborn, C. Woodworth, J.A. DiPaolo, and H.L. Bradlow The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis Int J Cancer 49 1991 867 869
33. E.L. Salazar, E. Mercado, I. Sojo, and M. Salcedo Relationship between estradiol 16 alpha-hydroxylation and human papillomavirus infection in cervical cell transformation Gynecol Endocrinol 15 2001 335 340 (Pubitemid 33096056)